Topical transport of hydrophilic compounds using water-in-oil nanoemulsions

International Journal of Pharmaceutics

Volumn 220, Issue 1-2, 2001, Pages 63-75

  Wu, Huailiang ^a   Ramachandran, Chandrasekharan ^a   Weiner, Norman D ^a   Roessler, Blake J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

HLB; Hydrophilic drug; Nanoemulsions; Sebum; Skin transport; Transfollicular

Indexed keywords

INULIN; OLIVE OIL; POLYSORBATE 80; SORBITAN OLEATE; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; EMULSION; HYDROPHILICITY; LIPOPHILICITY; MALE; MICELLE; MOLECULAR SIZE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; SKINFOLD THICKNESS;

ADMINISTRATION, TOPICAL; ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; INULIN; LINEAR MODELS; MALE; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; SPECIES SPECIFICITY;

EID: 0035806281     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00671-8     Document Type: Article

References (26)

1. Aboofazeli R., Patel N., Thomas M., Lawrence M.J. Investigations into the formation and characterization of phospholipid microemulsions. IV. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol and oil; the influence of oil. Int. J. Pharm. 125:1995;107-116.
2. Bolzinger M.A., Carduner T.C., Poelman M.C. Bicontinuous sucrose ester microemulsion: a new vehicle for topical delivery of niflumic acid. Int. J. Pharm. 176:1998;39-45.
3. Bronaugh R.L., Stewart R.F., Congdon E.R. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 62:1982;481-488.
4. Constantinides P.P., Scalart J.P., Lancaster C., Marcello J., Marks G., Ellens H., Smith P.L. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res. 11:1994;1385-1390.
5. Constantinides P.P., Lancaster C.M., Marcello J., Chiosone D.C., Orner D., Hidalgo I., Smith P.L., Sarkahian A.B., Yiv S.H., Owen A.J. Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and size. J. Control Release. 34:1995;109-116.
6. Constantinides P.P., Welzel G., Ellens H., Smith P.L., Sturgis S., Yiv S.H., Owen A.J. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation. Pharm. Res. 13:1996;210-215.
7. Delgado-Charro M.B., Iglesias-Vilas G., Blanco-Mendez J., Lopez-Quintela M.A., Marty J.-P., Guy R.H. Delivery of a hydrophobic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 43:1997;37-42.
8. Ho H.-O., Hsiao C.-C., Sheu M.-T. Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. J. Pharm. Sci. 85:1996;138-143.
9. Hueber F., Schaefer H., Wepeirre J. Role of transepidermal and transfollicular absorption of steroids: in vitro studies on human skin. Skin Pharmacol. 7:1994;237-244.
10. Illel B., Schaefer H., Wepierre J., Doucet O. Follicles play an important role in percutaneous absorption. J. Pharm. Sci. 80:1991;424-427.
11. Ktistis G., Niopas I. A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J. Pharm. Pharmacol. 50:1998;413-418.
12. Lauer A.C., Lieb L.M., Ramachandran C., Flynn G.L., Weiner N.D. Transfollicular drug delivery. Pharm. Res. 12:1995;179-186.
13. Lopez A., Llinares F., Cortell C., Herraez M. Comparative enhancer effects of Span®20 with Tween®20 and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicities. Int. J. Pharm. 202:2000;133-140.
14. Muller B.W., Muller R.H. Particle size analysis of latex suspensions and microemulsions by photon correlation spectroscopy. J. Pharm. Sci. 73:1984;915-918.
15. Niemiec S.M., Ramachandran C., Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. Pharm. Res. 12:1995;1184-1188.
16. Osborne D.W., Middleton C.A., Rogers R.L. Alcohol free microemulsions. J. Disp. Sci. Tech. 9:1988;415-423.
17. Osborne D.W., Ward A.J.I., O'Neill K.J. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J. Pharm. Pharmacol. 43:1991;451-454.
18. Schmalfub U., Neubert R., Wohlrab W. Modification of drug penetration into human skin using microemulsions. J. Control Rel. 46:1997;279-285.
19. Trotta M., Gasco M.R., Caputo O., Sancin P. Transcutaneous diffusion of hematoporphyrin in photodynamic therapy-in-vitro release from microemulsions. STP Pharma Sciences. 4:1994;150-154.
20. Trotta M., Pattarino F., Gasco M.R. Influence of counter ions on the skin permeation of methotrexate from water-in-oil microemulsions. Pharm. Acta Helv. 71:1996;135-140.
21. Trotta M., Morel S., Gasco M.R. Effect of oil phase composition on the skin permeation of felodipine from O/W microemulsions. Pharmazie. 52:1997;50-53.
22. Trotta M., Gallarate M., Pattarino F., Carlotti M.E. Investigation of the phase behaviour of systems containing lecithin and 2-acyl lysolecithin derivatives. Int. J. Pharm. 190:1999;83-89.
23. Wepierre J., Doucet O., Marty J.-P. Percutaneous absorption of drugs in vitro: role of transepidermal and transfollicular routes. Scott R.C., Guy R.H., Hadgraft J. Prediction of Percutaneous Penetration - Methods, Measurements, Modelling. 1990;129-134 IBC Technical Services Ltd. London.
24. 2O/AOT reverse microemulsions. J. Colloid Interf. Sci. 216:1999;303-308.
25. Wu, H.L., Ramachandran, C., Bielinska, A.U., Kingzett, K., Sun, R., Weiner, N.D., Roessler, B.J., submitted to Molecular Therapy, February 2000.
26. Yang L., Mao-Qiang M., Taljebini M., Elias P.M., Feingold K.R. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br. J. Dermatol. 133:1995;679-685.